Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products focused in four product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, and endoscopy.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment Wholesale
- Sub-Industry: Health Care Supplies
- Symbol: NASDAQ:MMSI
- CUSIP: 58988910
- Web: www.merit.com
Capitalization:- Market Cap: $2.04528 billion
- Outstanding Shares: 50,129,000
Average Prices:- 50 Day Moving Avg: $41.13
- 200 Day Moving Avg: $35.57
- 52 Week Range: $20.70 - $42.60
P/E:- Trailing P/E Ratio: 58.12
- Foreward P/E Ratio: 28.73
- P/E Growth: 3.57
Sales & Book Value:- Annual Revenue: $672.31 million
- Price / Sales: 3.04
- Book Value: $13.31 per share
- Price / Book: 3.07
Profitability:- EBIDTA: $101.84 million
- Net Margins: 4.87%
- Return on Equity: 9.78%
- Return on Assets: 5.72%
Debt:- Debt-to-Equity Ratio: 0.34%
- Current Ratio: 2.57%
- Quick Ratio: 1.38%
Misc:- Average Volume: 391,691 shs.
- Beta: 1.25
- Short Ratio: 3.25
Frequently Asked Questions for Merit Medical Systems (NASDAQ:MMSI)
What is Merit Medical Systems' stock symbol?
Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."
How were Merit Medical Systems' earnings last quarter?
Merit Medical Systems, Inc. (NASDAQ:MMSI) issued its quarterly earnings results on Wednesday, July, 26th. The company reported $0.36 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.29 by $0.07. The firm earned $186.50 million during the quarter, compared to analysts' expectations of $181.46 million. Merit Medical Systems had a return on equity of 9.78% and a net margin of 4.87%. The firm's revenue for the quarter was up 23.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.26 earnings per share. View Merit Medical Systems' Earnings History.
When will Merit Medical Systems make its next earnings announcement?
What guidance has Merit Medical Systems issued on next quarter's earnings?
Merit Medical Systems issued an update on its FY17 earnings guidance on Wednesday, July, 26th. The company provided EPS guidance of $1.23-$1.28 for the period, compared to the Thomson Reuters consensus estimate of $1.18. The company issued revenue guidance of $722-$727 million, compared to the consensus revenue estimate of $720.13 million.
Where is Merit Medical Systems' stock going? Where will Merit Medical Systems' stock price be in 2017?
10 brokerages have issued 1-year price objectives for Merit Medical Systems' stock. Their forecasts range from $20.00 to $50.00. On average, they expect Merit Medical Systems' stock price to reach $41.27 in the next year. View Analyst Ratings for Merit Medical Systems.
What are analysts saying about Merit Medical Systems stock?
Here are some recent quotes from research analysts about Merit Medical Systems stock:
- 1. According to Zacks Investment Research, "Merit Medical Systems, Inc. was formed for the purpose of producing single-use medical products of high quality and superior value primarily for use in diagnosis and treatment of cardiovascular disease. The company's products are designed to provide physicians and other health care professionals with devices that enable them to perform interventional and diagnostic procedures safely and effectively. " (6/22/2017)
- 2. Canaccord Genuity analysts commented, "We maintain our Buy rating on shares of MMSI but lower, albeit modestly, our price target from $35 to $33.50 due to modest dilution to our forward EPS targets from the recently completed secondary offering. To wit, the company completed a public offering of 4,500,000 shares of common stock at a price of $28.25 per share last Wednesday. The company raised nearly $125M in order to pay down some of its outstanding long term debt, which stood at $314M as of year-end 2016, including $180M revolving credit loans outstanding, not including an additional $38M of revolving credit loans to finance the Catheter connections purchase in early 1Q17. We see the secondary offering as prudent and necessary in order to remain at required leverage ratios. In short, we retain our thesis that stronger top-line revenue growth and expanding gross margins should continue to drive double-digit earnings growth – notwithstanding the offering dilution to share count – for the next few years at least." (3/27/2017)
Who are some of Merit Medical Systems' key competitors?
Some companies that are related to Merit Medical Systems include FibroGen (FGEN), Acadia Healthcare Company (ACHC), Opko Health (OPK), Clovis Oncology (CLVS), Integra LifeSciences Holdings Corporation (IART), Hikma Pharmaceuticals Plc (HKMPF), Molina Healthcare (MOH), ICU Medical (ICUI), Patterson Companies (PDCO), Cantel Medical Corp. (CMD), Nektar Therapeutics (NKTR), Mallinckrodt PLC (MNK), BeiGene (BGNE), LivaNova PLC (LIVN), Insulet Corporation (PODD), Evotec AG (EVTCY), Agios Pharmaceuticals (AGIO) and Hutchison China MediTech Limited (HCM).
Who are Merit Medical Systems' key executives?
Merit Medical Systems' management team includes the folowing people:
- Fred P. Lampropoulos, Chairman of the Board, President, Chief Executive Officer
- Bernard J. Birkett, Chief Financial Officer, Treasurer
- Joseph C. Wright, President - International Division
- Ronald A. Frost, Chief Operating Officer
- Justin J. Lampropoulos, Executive Vice President - Sales, Marketing and Strategy
- Brian G. Lloyd, Chief Legal Officer, Corporate Secretary
- Nolan E. Karras, Lead Independent Director
- David Ming-Teh Liu, Director
- Kent W. Stanger, Director
- A. Scott Anderson, Independent Director
Who owns Merit Medical Systems stock?
Merit Medical Systems' stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.64%), Vanguard Group Inc. (8.76%), Frontier Capital Management Co. LLC (5.48%), Dimensional Fund Advisors LP (5.39%), Ameriprise Financial Inc. (3.20%) and Janus Henderson Group PLC (3.06%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, F Ann Millner, Franklin J Miller, Kent W Stanger, Michael E Stillabower, Nolan E Karras and Richard W Edelman. View Institutional Ownership Trends for Merit Medical Systems.
Who sold Merit Medical Systems stock? Who is selling Merit Medical Systems stock?
Merit Medical Systems' stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Citadel Advisors LLC, Marshall Wace North America L.P., Voya Investment Management LLC, Goldman Sachs Group Inc., Tudor Investment Corp ET AL, Ameriprise Financial Inc. and Argent Capital Management LLC. Company insiders that have sold Merit Medical Systems stock in the last year include A Scott Anderson, F Ann Millner, Franklin J Miller, Kent W Stanger, Michael E Stillabower, Nolan E Karras and Richard W Edelman. View Insider Buying and Selling for Merit Medical Systems.
Who bought Merit Medical Systems stock? Who is buying Merit Medical Systems stock?
Merit Medical Systems' stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Frontier Capital Management Co. LLC, AMI Asset Management Corp, Russell Investments Group Ltd., Koch Industries Inc., Fiera Capital Corp, Columbus Circle Investors and Vanguard Group Inc.. View Insider Buying and Selling for Merit Medical Systems.
How do I buy Merit Medical Systems stock?
Shares of Merit Medical Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Merit Medical Systems' stock price today?
One share of Merit Medical Systems stock can currently be purchased for approximately $40.80.
MarketBeat Community Rating for Merit Medical Systems (NASDAQ MMSI)MarketBeat's community ratings are surveys of what our community members think about Merit Medical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Merit Medical Systems (NASDAQ:MMSI) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Hold Rating, 9 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.90) |
| Consensus Price Target: | $41.27 (1.15% upside) |
Analysts' Ratings History for Merit Medical Systems (NASDAQ:MMSI)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/6/2017 | Canaccord Genuity | Reiterated Rating | Buy | $45.00 | Low |  |
| 8/28/2017 | Raymond James Financial, Inc. | Reiterated Rating | Strong-Buy -> Outperform | $44.00 | Low | |
| 8/28/2017 | Citigroup Inc. | Downgrade | Strong-Buy -> Outperform | $44.00 | Low | |
| 7/28/2017 | Piper Jaffray Companies | Reiterated Rating | Buy | $45.00 | Low | |
| 7/27/2017 | Craig Hallum | Reiterated Rating | Buy | $42.00 -> $50.00 | High | |
| 7/20/2017 | Bank of America Corporation | Initiated Coverage | Buy -> Buy | $44.00 | Medium | |
| 6/28/2017 | Sidoti | Reiterated Rating | Buy | $41.00 -> $46.00 | Low | |
| 6/20/2017 | SunTrust Banks, Inc. | Initiated Coverage | Buy -> Buy | $43.00 | High | |
| 4/6/2017 | Keefe, Bruyette & Woods | Reiterated Rating | Hold | $20.00 | Low | |
| 4/5/2017 | Wells Fargo & Company | Initiated Coverage | Outperform | $17.94 -> $31.70 | Low | |
| 7/28/2016 | Barrington Research | Downgrade | Outperform -> Market Perform | | N/A | |
(Data available from 9/25/2015 forward)
Earnings History for Merit Medical Systems (NASDAQ:MMSI)Earnings History by Quarter for Merit Medical Systems (NASDAQ MMSI)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/24/2017 | | $0.30 | | | | | N/A | |
| 7/26/2017 | Q2 2017 | $0.29 | $0.36 | $181.46 million | $186.50 million | View | N/A | |
| 4/27/2017 | Q1 2017 | $0.23 | $0.28 | $163.50 million | $171.07 million | View | N/A | |
| 2/21/2017 | Q4 2016 | $0.28 | $0.31 | $160.39 million | $157.72 million | View | Listen | |
| 10/26/2016 | Q3 | $0.23 | $0.26 | $155.06 million | $157.00 million | View | Listen | |
| 7/27/2016 | Q2 | $0.24 | $0.26 | $147.76 million | $151.07 million | View | Listen | |
| 4/28/2016 | Q1 | $0.19 | $0.19 | $137.96 million | $138.10 million | View | Listen | |
| 2/22/2016 | Q4 | $0.22 | $0.24 | $138.73 million | $141.00 million | View | Listen | |
| 10/22/2015 | Q315 | $0.20 | $0.20 | $136.39 million | $136.10 million | View | Listen | |
| 7/23/2015 | Q215 | $0.20 | $0.25 | $135.82 million | $138.10 million | View | Listen | |
| 4/23/2015 | Q115 | $0.15 | $0.18 | $126.34 million | $129.60 million | View | Listen | |
| 2/24/2015 | Q414 | $0.20 | $0.26 | $132.76 million | $132.80 million | View | Listen | |
| 10/23/2014 | Q314 | $0.16 | $0.25 | $128.40 million | $128.80 million | View | Listen | |
| 7/29/2014 | Q214 | $0.17 | $0.15 | $121.40 million | $128.87 million | View | Listen | |
| 4/24/2014 | Q114 | $0.13 | $0.12 | $114.54 million | $119.20 million | View | Listen | |
| 2/24/2014 | Q413 | $0.19 | $0.22 | $117.26 million | $120.00 million | View | Listen | |
| 10/23/2013 | Q313 | $0.13 | $0.25 | $109.72 million | $115.20 million | View | Listen | |
| 7/31/2013 | Q2 2013 | $0.13 | $0.15 | $112.45 million | $109.87 million | View | Listen | |
| 4/25/2013 | Q1 2013 | $0.14 | $0.10 | $109.15 million | $103.90 million | View | Listen | |
| 2/21/2013 | Q4 2012 | $0.19 | $0.15 | $97.17 million | $102.23 million | View | Listen | |
| 10/25/2012 | | $0.16 | $0.20 | | | View | N/A | |
| 7/26/2012 | | $0.16 | $0.21 | | | View | N/A | |
| 2/23/2012 | | $0.18 | $0.18 | | | View | N/A | |
| 10/25/2011 | | $0.16 | $0.18 | | | View | N/A | |
| 7/21/2011 | | $0.20 | $0.21 | | | View | N/A | |
| 4/14/2011 | | $0.22 | $0.23 | | | View | N/A | |
| 2/17/2011 | | $0.21 | $0.23 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Merit Medical Systems (NASDAQ:MMSI)2017 EPS Consensus Estimate: $1.14
2018 EPS Consensus Estimate: $1.41
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | $0.22 | $0.22 | $0.22 |
| Q2 2017 | 2 | $0.28 | $0.31 | $0.30 |
| Q3 2017 | 2 | $0.31 | $0.31 | $0.31 |
| Q4 2017 | 2 | $0.30 | $0.33 | $0.32 |
| Q1 2018 | 2 | $0.27 | $0.32 | $0.30 |
| Q2 2018 | 2 | $0.37 | $0.38 | $0.38 |
| Q3 2018 | 2 | $0.34 | $0.37 | $0.36 |
| Q4 2018 | 2 | $0.37 | $0.39 | $0.38 |
(Data provided by Zacks Investment Research)
Dividend History for Merit Medical Systems (NASDAQ:MMSI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Merit Medical Systems (NASDAQ:MMSI)Insider Ownership Percentage: 5.00%
Institutional Ownership Percentage: 89.11%
Insider Trades by Quarter for Merit Medical Systems (NASDAQ:MMSI)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 9/14/2017 | Kent W. Stanger | Director | Sell | 670 | $42.06 | $28,180.20 | |
| 9/11/2017 | Kent W. Stanger | Director | Sell | 1,930 | $42.02 | $81,098.60 | |
| 8/8/2017 | Kent W. Stanger | Director | Sell | 7,400 | $42.22 | $312,428.00 | |
| 8/7/2017 | A Scott Anderson | Director | Sell | 25,000 | $41.15 | $1,028,750.00 | |
| 8/3/2017 | F. Ann Millner | Director | Sell | 3,106 | $41.01 | $127,377.06 | |
| 8/1/2017 | Richard W Edelman | Insider | Sell | 29,000 | $41.19 | $1,194,510.00 | |
| 6/30/2017 | Richard W Edelman | Insider | Sell | 20,000 | $37.62 | $752,400.00 | |
| 6/28/2017 | F. Ann Millner | Director | Sell | 6,744 | $38.15 | $257,283.60 | |
| 6/27/2017 | Nolan E Karras | Director | Sell | 7,000 | $37.15 | $260,050.00 | |
| 5/25/2017 | Richard W Edelman | Director | Sell | 16,000 | $34.46 | $551,360.00 | |
| 5/19/2017 | Michael E Stillabower | Director | Sell | 17,110 | $33.71 | $576,778.10 | |
| 5/15/2017 | Franklin J Miller | Director | Sell | 16,090 | $33.95 | $546,255.50 | |
| 12/9/2016 | Kent W. Stanger | Director | Sell | 12,000 | $26.27 | $315,240.00 | |
| 8/30/2016 | A Scott Anderson | Director | Sell | 12,000 | $24.10 | $289,200.00 | |
| 8/15/2016 | Michael E Stillabower | Director | Sell | 25,000 | $24.29 | $607,250.00 | |
| 8/12/2016 | Richard W Edelman | Director | Sell | 21,500 | $23.51 | $505,465.00 | |
| 8/9/2016 | Richard W Edelman | Director | Sell | 500 | $23.55 | $11,775.00 | |
| 8/2/2016 | Nolan E Karras | Director | Sell | 5,878 | $23.35 | $137,251.30 | |
| 8/1/2016 | Franklin J Miller | Director | Sell | 15,000 | $23.52 | $352,800.00 | |
| 3/3/2016 | Kent W. Stanger | CFO | Sell | 20,000 | $18.89 | $377,800.00 | |
| 4/27/2015 | Franklin J Miller | Director | Sell | 10,000 | $21.05 | $210,500.00 | |
| 3/23/2015 | Franklin J Miller | Director | Sell | 8,750 | $19.72 | $172,550.00 | |
| 3/16/2015 | Franklin J Miller | Director | Sell | 8,750 | $19.47 | $170,362.50 | |
| 3/16/2015 | Ronald Frost | COO | Sell | 11,250 | $19.50 | $219,375.00 | |
| 12/29/2014 | Franklin J Miller | Director | Sell | 10,000 | $17.36 | $173,600.00 | |
| 12/24/2014 | A Scott Anderson | Director | Sell | 12,000 | $17.03 | $204,360.00 | |
| 12/22/2014 | Martin R Stephens | VP | Sell | 14,999 | $16.75 | $251,233.25 | |
| 12/18/2014 | Greg L Barnett | CAO | Sell | 10,000 | $16.91 | $169,100.00 | |
| 10/28/2014 | Greg L Barnett | CAO | Sell | 12,500 | $15.00 | $187,500.00 | |
| 10/27/2014 | Rashelle Perry | Insider | Sell | 12,500 | $14.85 | $185,625.00 | |
| 10/24/2014 | Kent W Stanger | CFO | Sell | 18,000 | $14.00 | $252,000.00 | |
| 7/10/2014 | Kent W Stanger | CFO | Sell | 6,000 | $14.76 | $88,560.00 | |
| 6/19/2014 | Ronald Frost | COO | Sell | 5,000 | $14.25 | $71,250.00 | |
| 6/10/2014 | Kent W Stanger | CFO | Sell | 6,000 | $14.02 | $84,120.00 | |
| 6/9/2014 | Kent W Stanger | CFO | Sell | 22,137 | $14.11 | $312,353.07 | |
| 6/3/2014 | Ronald Frost | COO | Sell | 2,325 | $14.07 | $32,712.75 | |
| 5/27/2014 | Kent W Stanger | CFO | Sell | 15,880 | $14.18 | $225,178.40 | |
| 5/21/2014 | Kent Stanger | CFO | Sell | 22,259 | $14.00 | $311,626.00 | |
| 5/16/2014 | Kent Stanger | CFO | Sell | 9,991 | $14.00 | $139,874.00 | |
| 5/15/2014 | Richard Edelman | Director | Sell | 11,270 | $13.93 | $156,991.10 | |
| 4/10/2014 | Kent Stanger | CFO | Sell | 6,000 | $14.17 | $85,020.00 | |
| 3/10/2014 | Kent Stanger | CFO | Sell | 6,000 | $14.40 | $86,400.00 | |
| 11/22/2013 | Richard Edelman | Director | Sell | 16,027 | $16.49 | $264,285.23 | |
| 10/30/2013 | Rashelle Perry | Insider | Sell | 16,250 | $16.40 | $266,500.00 | |
| 10/29/2013 | Michael E Stillabower | Director | Sell | 37,500 | $16.41 | $615,375.00 | |
| 10/28/2013 | Greg L Barnett | CAO | Sell | 16,250 | $16.45 | $267,312.50 | |
| 10/25/2013 | Franklin J Miller | Director | Sell | 7,500 | $16.71 | $125,325.00 | |
| 10/25/2013 | Martin R Stephens | VP | Sell | 32,500 | $16.64 | $540,800.00 | |
| 5/22/2013 | Rex C Bean | Director | Sell | 13,000 | $10.09 | $131,170.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Merit Medical Systems (NASDAQ:MMSI)
Latest Headlines for Merit Medical Systems (NASDAQ:MMSI)
| Source: |
|
| Date | Headline |
|---|
 | Analysts Expect Merit Medical Systems, Inc. (MMSI) Will Announce Quarterly Sales of $182.27 Million
www.americanbankingnews.com - September 24 at 1:04 AM |
| Kent W. Stanger Sells 670 Shares of Merit Medical Systems, Inc. (MMSI) Stock
www.americanbankingnews.com - September 18 at 4:16 PM |
 | Young America Capital Successfully Assisted Pleuratech in Entering Into an Exclusive Worldwide License Agreement With Merit Medical
finance.yahoo.com - September 14 at 7:46 AM |
| Merit Medical Systems, Inc. (MMSI) Director Kent W. Stanger Sells 1,930 Shares
www.americanbankingnews.com - September 13 at 8:52 PM |
| Critical Review: Owens & Minor (OMI) versus Merit Medical Systems (MMSI)
www.americanbankingnews.com - September 11 at 1:06 PM |
| Merit Medical Systems' (MMSI) Buy Rating Reiterated at Canaccord Genuity
www.americanbankingnews.com - September 10 at 10:10 PM |
| Head-To-Head Analysis: Merit Medical Systems (MMSI) versus Owens & Minor (OMI)
www.americanbankingnews.com - September 10 at 4:08 PM |
| Merit Medical Systems, Inc. (MMSI) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - September 7 at 12:30 AM |
| $182.27 Million in Sales Expected for Merit Medical Systems, Inc. (MMSI) This Quarter
www.americanbankingnews.com - September 6 at 1:28 PM |
| Merit Medical Systems, Inc. (MMSI) Expected to Announce Earnings of $0.30 Per Share
www.americanbankingnews.com - September 4 at 2:08 AM |
 | Merit Medical to Participate at Five Conferences
feeds.benzinga.com - August 29 at 10:11 AM |
 | Raymond James Downgrades Merit Medical Systems, Inc. (MMSI) to Outperform
www.streetinsider.com - August 28 at 3:31 PM |
| Merit Medical Systems, Inc. (MMSI) Cut to Outperform at UBS AG
www.americanbankingnews.com - August 28 at 12:00 PM |
| Merit Medical Systems, Inc. (MMSI) Rating Lowered to Outperform at Citigroup Inc.
www.americanbankingnews.com - August 28 at 10:10 AM |
| Raymond James Financial, Inc. Reiterates Outperform Rating for Merit Medical Systems, Inc. (MMSI)
www.americanbankingnews.com - August 28 at 9:36 AM |
| Critical Survey: Cantel Medical Corp. (CMD) and Merit Medical Systems (MMSI)
www.americanbankingnews.com - August 19 at 6:28 PM |
| See what the IHS Markit Score report has to say about Merit Medical Systems Inc.
finance.yahoo.com - August 18 at 1:40 AM |
| Cramer's lightning round: I don't want to recommend any oil stocks right now
finance.yahoo.com - August 17 at 8:39 PM |
| Cantel Medical Corp. (CMD) vs. Merit Medical Systems (MMSI) Head-To-Head Analysis
www.americanbankingnews.com - August 15 at 10:28 PM |
| Merit Medical Systems, Inc. (MMSI) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - August 13 at 12:32 AM |
| Cantel Medical Corp. (CMD) versus Merit Medical Systems (NASDAQ:MMSI) Financial Comparison
www.americanbankingnews.com - August 12 at 2:14 AM |
| Kent W. Stanger Sells 7,400 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock
www.americanbankingnews.com - August 9 at 8:46 PM |
| Merit Medical Systems, Inc. (NASDAQ:MMSI) Director A Scott Anderson Sells 25,000 Shares
www.americanbankingnews.com - August 8 at 7:44 PM |
| Merit Medical Systems, Inc. (MMSI) Director Sells $127,377.06 in Stock
www.americanbankingnews.com - August 7 at 4:14 PM |
| Reviewing Merit Medical Systems (MMSI) and Cantel Medical Corp. (CMD)
www.americanbankingnews.com - August 2 at 7:18 AM |
| Q3 2017 EPS Estimates for Merit Medical Systems, Inc. Raised by SunTrust Banks (NASDAQ:MMSI)
www.americanbankingnews.com - August 2 at 7:02 AM |
| Insider Selling: Merit Medical Systems, Inc. (MMSI) Insider Sells 29,000 Shares of Stock
www.americanbankingnews.com - August 1 at 10:13 PM |
| Barrington Research Brokers Boost Earnings Estimates for Merit Medical Systems, Inc. (NASDAQ:MMSI)
www.americanbankingnews.com - July 31 at 8:09 AM |
| Merit Medical Systems, Inc. (MMSI) to Post Q3 2017 Earnings of $0.31 Per Share, Barrington Research Forecasts
www.americanbankingnews.com - July 28 at 11:00 AM |
| Merit Medical Systems, Inc. (MMSI) Rating Reiterated by Piper Jaffray Companies
www.americanbankingnews.com - July 28 at 7:53 AM |
| Edited Transcript of MMSI earnings conference call or presentation 26-Jul-17 9:00pm GMT
finance.yahoo.com - July 28 at 5:14 AM |
| Merit Medical tops Street 2Q forecasts
finance.yahoo.com - July 28 at 5:14 AM |
| Merit Medical Reports Record Revenue and Non-GAAP Net Income* for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance
finance.yahoo.com - July 27 at 4:25 AM |
| Merit Medical Systems, Inc. (MMSI) Issues Quarterly Earnings Results
www.americanbankingnews.com - July 26 at 9:15 PM |
| Merit Medical Systems, Inc. (MMSI) Releases FY17 Earnings Guidance
www.americanbankingnews.com - July 26 at 7:22 PM |
| Merit Medical Systems, Inc. (NASDAQ:MMSI) Coverage Initiated at Bank of America Corporation
www.americanbankingnews.com - July 20 at 7:45 PM |
| Merit Medical Systems, Inc. (MMSI) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - July 19 at 12:15 AM |
| Merit Medical Systems to Announce Second Quarter Results on July 26, 2017
finance.yahoo.com - July 11 at 2:08 AM |
| ETFs with exposure to Merit Medical Systems, Inc. : July 7, 2017
finance.yahoo.com - July 8 at 12:41 PM |
| Zacks: Brokerages Expect Merit Medical Systems, Inc. (NASDAQ:MMSI) Will Announce Quarterly Sales of $181.60 Million
www.americanbankingnews.com - July 7 at 2:42 PM |
| Merit Medical Systems, Inc. (NASDAQ:MMSI) Insider Sells $752,400.00 in Stock
www.americanbankingnews.com - July 5 at 10:22 PM |
| Brokerages Expect Merit Medical Systems, Inc. (MMSI) Will Announce Earnings of $0.29 Per Share
www.americanbankingnews.com - July 5 at 7:44 AM |
| Merit Medical Systems, Inc. (MMSI) Director F. Ann Millner Sells 6,744 Shares
www.americanbankingnews.com - June 29 at 8:11 PM |
| Nolan E. Karras Sells 7,000 Shares of Merit Medical Systems, Inc. (MMSI) Stock
www.americanbankingnews.com - June 29 at 1:29 PM |
| Merit Medical Systems, Inc. (MMSI) Earns Buy Rating from Sidoti
www.americanbankingnews.com - June 28 at 11:59 AM |
| Merit Medical Systems, Inc. (MMSI) Upgraded at BidaskClub
www.americanbankingnews.com - June 28 at 12:04 AM |
| Merit Medical Systems, Inc. (MMSI) Earns Overweight Rating from Piper Jaffray Companies
www.americanbankingnews.com - June 26 at 5:50 PM |
| Merit Medical Systems, Inc. (MMSI) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - June 25 at 12:36 PM |
| Merit Medical Systems, Inc. (MMSI) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - June 24 at 12:50 AM |
| Merit Medical’s Embosphere® Microspheres Receive FDA 513(f)(2) (de novo) Classification for Prostatic Artery Embolization Indication
finance.yahoo.com - June 23 at 8:02 AM |
Merit Medical Systems (MMSI) Chart for Monday, September, 25, 2017
